See also this year's filing and all EDGAR filings for this company.
PDF Report 0001399529_2020_Dicerna_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.0002564928872549342, 'aggregate_val': 152090000, 'exp_sum': 152051000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 42751000, 'ResearchAndDevelopmentExpense': 109300000, 'remainder_Expenses': 0}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001399529')"} |
Graph
Absolute values for 0001399529, Dicerna Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 556,169,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,076,000 |
| 3 | remainder_Assets | 34,164,000 |
| 4 | LiabilitiesCurrent | 241,735,000 |
| 5 | LiabilitiesNoncurrent | 203,479,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 42,751,000 |
| 9 | ResearchAndDevelopmentExpense | 109,300,000 |
| 10 | remainder_Expenses | 39,000 |
| 11 | remainder_Revenues | 23,904,000 |
| 12 | remainder_NetIncome | 7,727,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 597,409,000 |
| 1 | Liabilities | 445,214,000 |
| 2 | Expenses | 152,090,000 |
| 3 | Revenues | 23,904,000 |
| 4 | StockholdersEquity | 152,195,000 |
| 5 | NetIncome | -120,459,000 |
| 6 | ComprehensiveNetIncome | -120,459,000 |
| 7 | BaseVar | 613,172,000 |
| 8 | EconomicCapitalRatio | 0.271 |
Edgar->Model Mapping
Feature Distribution
Change over Time
